RecruitingNot ApplicableNCT04662905
Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
Sponsor
Saluda Medical Pty Ltd
Enrollment
200 participants
Start Date
Dec 15, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- \. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
- \. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEEvoke Spinal Cord Stimulation (SCS) System
ECAP-controlled, closed-loop SCS
Locations(23)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04662905
Related Trials
Life-Style Medicine for Chronic Musculoskeletal Pain in Older People
NCT071942391 location
Mechanistic Study of Personalized rTMS in Chronic Pain
NCT072661031 location
Mechanisms of Mindfulness Meditation and Self-Hypnosis for Pain in Older Adults With Chronic Pain
NCT069577431 location
Patient Retrospective Outcomes (PRO)
NCT01550575143 locations
CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial
NCT060270994 locations